GR3033644T3 - Protein expression system. - Google Patents

Protein expression system.

Info

Publication number
GR3033644T3
GR3033644T3 GR20000401331T GR20000401331T GR3033644T3 GR 3033644 T3 GR3033644 T3 GR 3033644T3 GR 20000401331 T GR20000401331 T GR 20000401331T GR 20000401331 T GR20000401331 T GR 20000401331T GR 3033644 T3 GR3033644 T3 GR 3033644T3
Authority
GR
Greece
Prior art keywords
expression
vector
host cell
resin
fusion protein
Prior art date
Application number
GR20000401331T
Other languages
English (en)
Inventor
Carl Spana
Joseph Fargnoli
Joseph B Bolen
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of GR3033644T3 publication Critical patent/GR3033644T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/14011—Baculoviridae
    • C12N2710/14111—Nucleopolyhedrovirus, e.g. autographa californica nucleopolyhedrovirus
    • C12N2710/14141—Use of virus, viral particle or viral elements as a vector
    • C12N2710/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Virology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Plant Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
GR20000401331T 1993-09-30 2000-06-12 Protein expression system. GR3033644T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/129,722 US6303369B1 (en) 1993-09-30 1993-09-30 Protein expression system

Publications (1)

Publication Number Publication Date
GR3033644T3 true GR3033644T3 (en) 2000-10-31

Family

ID=22441291

Family Applications (1)

Application Number Title Priority Date Filing Date
GR20000401331T GR3033644T3 (en) 1993-09-30 2000-06-12 Protein expression system.

Country Status (10)

Country Link
US (1) US6303369B1 (el)
EP (1) EP0646646B1 (el)
JP (1) JP3497253B2 (el)
AT (1) ATE190664T1 (el)
CA (1) CA2132937A1 (el)
DE (1) DE69423409T2 (el)
DK (1) DK0646646T3 (el)
ES (1) ES2146242T3 (el)
GR (1) GR3033644T3 (el)
PT (1) PT646646E (el)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9513683D0 (en) 1995-07-05 1995-09-06 Ciba Geigy Ag Products
WO1998003649A1 (en) * 1996-07-24 1998-01-29 Pharmacia & Upjohn Company Constructs and complexes of cyclin e
US6056954A (en) 1997-10-31 2000-05-02 New Horizons Diagnostics Corp Use of bacterial phage associated lysing enzymers for the prophylactic and therapeutic treatment of various illnesses
US6432444B1 (en) 1997-10-31 2002-08-13 New Horizons Diagnostics Corp Use of bacterial phage associated lysing enzymes for treating dermatological infections
US6428784B1 (en) 1997-10-31 2002-08-06 New Horizons Diagnostics Corp Vaginal suppository for treating group B Streptococcus infection
US6406692B1 (en) 1997-10-31 2002-06-18 New Horizons Diagnostics Corp Composition for treatment of an ocular bacterial infection
US6752988B1 (en) 2000-04-28 2004-06-22 New Horizons Diagnostic Corp Method of treating upper resiratory illnesses
US6277399B1 (en) 1997-10-31 2001-08-21 New Horizon Diagnostics Corporation Composition incorporating bacterial phage associated lysing enzymes for treating dermatological infections
US6423299B1 (en) 1997-10-31 2002-07-23 Vincent Fischetti Composition for treatment of a bacterial infection of an upper respiratory tract
US7232576B2 (en) 1997-10-31 2007-06-19 New Horizons Diagnostics Corp Throat lozenge for the treatment of Streptococcus Group A
WO2000050616A2 (en) * 1999-02-24 2000-08-31 University Technologies International Inc. Sequences for improving the efficiency of secretion of non-secreted proteins from mammalian and insect cells
IL129427A0 (en) * 1999-04-13 2000-02-17 Yeda Res & Dev Preparation of biologically active molecules
US7063837B2 (en) 1999-09-14 2006-06-20 New Horizons Diagnostics Corp Syrup composition containing phage associated lytic enzymes
WO2004113530A1 (ja) * 2003-06-18 2004-12-29 Mitsubishi Chemical Corporation ラベル化蛋白質合成用ポリヌクレオチド
DE602005023534D1 (de) * 2005-01-25 2010-10-21 Seng Entpr Ltd Mikrofluidische vorrichtung zur untersuchung zellen
JP5307716B2 (ja) 2007-08-27 2013-10-02 シスメックス株式会社 ドックリンポリペプチドおよびそれを利用した組換え融合タンパク質の精製方法
US9562077B2 (en) * 2012-07-11 2017-02-07 Children's Hospital Medical Center Protein complex system for increased immunogenicity and functionality, and methods making and use
WO2018182983A1 (en) 2017-03-28 2018-10-04 Children's Hospital Medical Center Norovirus s particle based vaccines and methods of making and using same

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ224663A (en) 1987-05-28 1990-11-27 Amrad Corp Ltd Fusion proteins containing glutathione-s-transferase and expression of foreign polypeptides using glutathione-s-transferase encoding vectors
AU7766391A (en) * 1990-04-23 1991-11-11 Corvas International N.V. Thrombus-specific antibody derivatives

Also Published As

Publication number Publication date
EP0646646A2 (en) 1995-04-05
EP0646646B1 (en) 2000-03-15
DK0646646T3 (da) 2000-06-05
EP0646646A3 (en) 1996-06-12
ATE190664T1 (de) 2000-04-15
ES2146242T3 (es) 2000-08-01
DE69423409T2 (de) 2000-10-26
US6303369B1 (en) 2001-10-16
JPH07184663A (ja) 1995-07-25
DE69423409D1 (de) 2000-04-20
JP3497253B2 (ja) 2004-02-16
CA2132937A1 (en) 1995-03-31
PT646646E (pt) 2000-07-31

Similar Documents

Publication Publication Date Title
GR3033644T3 (en) Protein expression system.
ATE206161T1 (de) Cd 19 kodierende dna
CA2089094A1 (en) Expression of recombinant polypeptides with improved purification
CA2245006A1 (en) Protein expression system
ATE152174T1 (de) Verfahren zur herstellung von fusionsproteinen
WO1999007735A3 (en) Recombinant expression of insulin c-peptide
AR012499A1 (es) Una secuencia quimerica de acido nucleico que codifica una proteina de fusion, un vector de expresion que comprende dicha secuencia quimerica, una celula huesped transformada que contiene dicho vector, la proteina de fusion obtenida y un metodo in vitro para la preparacion de un polipeptido recombin
CA2340974A1 (en) Method for purifying proteins and/or biomolecule or protein complexes
DK0453969T3 (el)
EP1188826A3 (en) 5-substituted hydantoin racemase, DNA coding for the same, and process for producing optically active amino acids
DE69401490T2 (de) Prozess zur Rückfaltung von (pro-)Chymosin, unter Rückführung von Harnstoff
AU7649996A (en) Fused DNA sequence, fused protein expressed from said fused DNA sequence and method for expressing said protein
SE8802939D0 (sv) A method for the production and isolation of a fusion protein in eukaryotic cells
KR900008040A (ko) 스트렙토마이세테스 내에서 인슐린 전구체를 제조하는 방법
AU650038B2 (en) CKS method of protein synthesis
DK0725822T3 (da) Fremgangsmåde til rekombinant fremstilling af proteiner i gær
CA2175068A1 (en) The recombinant production of proteins in yeast
WO1996036722A3 (en) Embedded expression of heterologous proteins

Legal Events

Date Code Title Description
ML Lapse due to non-payment of fees